Cargando…
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives Dave Singh
Fixed dose combination (FDC) dual bronchodilators that co-administer a long acting β(2)-adrenoceptor agonist (LABA) and a long acting muscarinic antagonist (LAMA) are a new class of inhaled treatment for chronic obstructive pulmonary disease (COPD). This review focuses on the clinical evidence for t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BlackWell Publishing Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415707/ https://www.ncbi.nlm.nih.gov/pubmed/25377687 http://dx.doi.org/10.1111/bcp.12545 |